CSC(SH:601066) Mei Ri Jing Ji Xin Wen·2025-07-18 05:56Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index decreased by 0.46% as of July 18, 2025, with mixed performance among constituent stocks [1] - BoRui Pharmaceutical led the gains with an increase of 6.37%, while Yuanjie Technology experienced the largest decline at 4.94% [1] - The Huaxia Sci-Tech 100 ETF (588800) fell by 0.49%, with a latest price of 1.01 yuan and a turnover rate of 5.36%, amounting to a transaction volume of 158 million yuan [1] Group 2 - CITIC Securities highlights that despite increasing external challenges, the competitiveness of China's pharmaceutical industry continues to rise, with innovative drugs gaining international recognition [2] - China possesses advantages in population and domestic demand, manufacturing and supply chain, while its innovation capabilities are rapidly improving [2] - The Huaxia Sci-Tech 100 ETF (588800) shows that stocks with a market capitalization below 20 billion yuan account for 80% of its holdings, indicating a focus on small-cap stocks [2]